Skip to content
★ Sign in to follow
JS

John Simon Craw

CEO
International Stem Cell Corp
Total declarations
6
Company
1
▲ Purchases (5 ops.)
€3,104
▼ Sales (0 ops.)
—

Latest filing published 10 Oct 2014 for International Stem Cell CORP, €788.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-27.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John Simon Craw: trading record in brief

This profile gathers the share dealings of John Simon Craw in International Stem Cell Corp. Between 4 September 2012 and 10 October 2014, the trades on record add up to 6 filings.

Every open-market trade on record is a purchase: 5 purchases worth €3,104, and no sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. Since January 2014: 4 purchases and no sales on the market.

Half of the purchases are above €779 and half below.

Most recently, on 10 October 2014, the filings show an open-market purchase worth €788 in International Stem Cell Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John Simon Craw

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total

4 of 4 declarations